Detalhe da pesquisa
1.
Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progression.
Hum Mol Genet
; 33(8): 698-708, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38268317
2.
Longitudinal measures of RNA expression and disease activity in FSHD muscle biopsies.
Hum Mol Genet
; 29(6): 1030-1043, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32083293
3.
Quantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole-body fat-referenced MRI: Protocol development, multicenter feasibility, and repeatability.
Muscle Nerve
; 66(2): 183-192, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35585766
4.
MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD.
Hum Mol Genet
; 28(3): 476-486, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30312408
5.
Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial.
Muscle Nerve
; 63(3): 371-383, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33340120
6.
Adapting MRI as a clinical outcome measure for a facioscapulohumeral muscular dystrophy trial of prednisone and tacrolimus: case report.
BMC Musculoskelet Disord
; 22(1): 56, 2021 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33422031
7.
Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy.
BMC Musculoskelet Disord
; 22(1): 262, 2021 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33691664
8.
MRI change metrics of facioscapulohumeral muscular dystrophy: Stir and T1.
Muscle Nerve
; 57(6): 905-912, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29236297
9.
Defining SOD1 ALS natural history to guide therapeutic clinical trial design.
J Neurol Neurosurg Psychiatry
; 88(2): 99-105, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27261500
10.
Facioscapulohumeral Dystrophy.
Curr Neurol Neurosci Rep
; 16(7): 66, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27215221
11.
Pain in hereditary neuropathy with liability to pressure palsy: an association with fibromyalgia syndrome?
Muscle Nerve
; 51(3): 385-90, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25042093
12.
Relationship Between Hand Function and Handheld Ultrasound Imaging in Inclusion Body Myositis.
J Clin Neuromuscul Dis
; 25(3): 115-121, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38441927
13.
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial.
Lancet Neurol
; 23(5): 477-486, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38631764
14.
A muscle strength enhancer for all seasons?
Muscle Nerve
; 57(5): 697-698, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29266321
15.
Validation of the association between MRI and gene signatures in facioscapulohumeral dystrophy muscle: implications for clinical trial design.
bioRxiv
; 2023 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36865168
16.
Lean tissue mass measurements by dual-energy X-ray absorptiometry and associations with strength and functional outcome measures in facioscapulohumeral muscular dystrophy.
Neuromuscul Disord
; 33(9): 63-68, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37400350
17.
Correlations of disease severity outcome measures in inclusion body myositis.
Neuromuscul Disord
; 32(10): 800-805, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36050251
18.
Current Therapeutic Approaches in FSHD.
J Neuromuscul Dis
; 8(3): 441-451, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33579868
19.
Clinical utility of anti-cytosolic 5'-nucleotidase 1A antibody in idiopathic inflammatory myopathies.
Ann Clin Transl Neurol
; 8(3): 571-578, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33556224
20.
Optimizing hand-function patient outcome measures for inclusion body myositis.
Neuromuscul Disord
; 30(10): 807-814, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32928647